Clinical Trial Update: Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cisplatin, docetaxel, and pembrolizumab for stage II–III laryngeal squamous cell carcinoma; the study is active but not recruiting, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Squamous Cell Carcinoma

Drugs mentioned

• Cisplatin (Platinol) (cisplatin)
• Docetaxel (Taxotere) (docetaxel)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Laryngeal Squamous Cell Carcinoma, Stage II Laryngeal Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-17